Ejemplares similares: MERS coronavirus neutralizing antibodies in camels, eastern Africa, 1983-1997
- Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992 - 2013
- Link of a ubiquitous human coronavirus to dromedary camels
- MERS-CoV antibodies in humans, Africa, 2013–2014
- Middle East respiratory syndrome coronavirus (MERS-CoV) seropositive camel handlers in Kenya
- Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983–2015
- Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
Autor: Muller, M.A.
Autor: Corman, V.M.
- Genomic characterization and antimicrobial susceptibility of dromedary-associated Staphylococcaceae from the Horn of Africa
- MERS-CoV antibodies in humans, Africa, 2013–2014
- Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
- Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983–2015
- Link of a ubiquitous human coronavirus to dromedary camels
- MERS coronavirus neutralizing antibodies in camels, eastern Africa, 1983-1997